Position in PBH
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$3,596,207
-$3,920,719 QoQ
Shares Held
60,675
-50.2% QoQ
Ownership
0.128%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in PBH Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026PRUDENTIAL FINANCIAL INC holds $156,211,352 across 33 Drug Manufacturers - Specialty & Generic names. PBH ranks #13 (2.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | NBIX |
Neurocrine Biosciences Inc
|
225,051 | $29,648,218 | |
| 2 | ZTS |
Zoetis Inc.
|
202,071 | $23,886,812 | |
| 3 | UTHR |
UNITED THERAPEUTICS Corp
|
34,281 | $20,327,947 | |
| 4 | ELAN |
Elanco Animal Health Inc
|
449,847 | $10,764,838 | |
| 5 | INDV |
Indivior Pharmaceuticals, Inc.
|
286,100 | $8,720,328 | |
| 6 | VTRS |
Viatris Inc
|
597,766 | $8,075,817 | |
| 7 | AMRX |
Amneal Pharmaceuticals, Inc.
|
511,957 | $6,363,625 | |
| 8 | TEVA |
Teva Pharmaceutical Industries Ltd
|
207,156 | $6,239,538 |
All Filings in PBH
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $3,596,207 | 60,675 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $7,516,926 | 121,850 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $7,982,395 | 127,923 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $10,851,854 | 135,903 | Shares | Defined | 2025-08-12 | |
| 2025-03-31 | $13,022,563 | 151,478 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $12,610,988 | 161,493 | Shares | Defined | 2025-02-11 | |
| 2024-09-30 | $13,269,572 | 184,044 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $11,622,086 | 168,803 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $10,783,359 | 148,613 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $9,365,619 | 152,983 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $9,584,243 | 167,586 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $9,827,107 | 165,356 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $9,806,354 | 156,576 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $11,617,683 | 185,586 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $9,426,889 | 189,181 | Shares | Defined | 2022-11-04 | |
| 2022-06-30 | $18,589,972 | 316,156 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $14,987,631 | 283,106 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $16,609,972 | 273,866 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $20,241,120 | 360,740 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $21,145,305 | 405,860 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $19,623,445 | 445,178 | Shares | Defined | 2021-05-12 | |
| 2020-12-31 | $21,603,879 | 619,555 | Shares | Defined | 2021-08-16 | |
| 2020-09-30 | $18,413,113 | 505,577 | Shares | Defined | 2020-11-16 | |
| 2020-06-30 | $12,873,952 | 342,757 | Shares | Defined | 2020-08-12 | |
| 2020-03-31 | $4,218,859 | 115,018 | Shares | Defined | 2020-05-12 | |
| No filing history on record for this holder in this stock. | ||||||